九典制药：拟使用自有资金5000万元与湘江善诺、玖智轻研共同投资设立湖南九典善诺创新医药科技有限公司

Core Viewpoint - The company plans to invest 50 million yuan of its own funds to establish Hunan Jiutian Shanno Innovative Pharmaceutical Technology Co., Ltd. in partnership with two other firms [1] Group 1 - The registered capital of Hunan Jiutian Shanno is set at 100 million yuan, with the company holding a 50% stake [1] - Changsha Xiangjiang Shanno Venture Capital Partnership holds a 30% stake, while Hainan Jiu Zhi Qing Yan Technology Partnership holds a 20% stake [1] - This investment is classified as a related party transaction but does not constitute a major asset reorganization [1]